Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Microsoft
MSFT
|
+$197M |
| 2 |
Amazon
AMZN
|
+$146M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Prologis
PLD
|
+$130M |
| 5 |
Digital Realty Trust
DLR
|
+$93.4M |
Top Sells
| 1 |
Trane Technologies
TT
|
+$187M |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$111M |
| 4 |
LPT
Liberty Property Trust
LPT
|
+$105M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$25.3M |
Sector Composition
| 1 | Technology | 21.16% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 13.29% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Option Care Health
OPCH
$4.71B
| $64K | ﹤0.01% |
6,782
-1,525
| -18% | -$14.4K |
|
2527
Puma Biotechnology
PBYI
$226M
| $64K | ﹤0.01% |
7,584
-1,361
| -15% | -$11.5K |
|
|
EVFM
2528
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $64K | ﹤0.01% |
802
-57
| -7% | -$4.55K |
|
|
ACRE
2529
Ares Commercial Real Estate
ACRE
$267M
| $63K | ﹤0.01% |
8,942
-188
| -2% | -$1.33K |
|
2530
CytomX Therapeutics
CTMX
$335M
| $63K | ﹤0.01% |
8,273
-2,549
| -24% | -$19.4K |
|
|
CLVS
2531
DELISTED
Clovis Oncology, Inc.
CLVS
| $63K | ﹤0.01% |
9,907
-13,642
| -58% | -$86.8K |
|
|
VRS
2532
DELISTED
Verso Corporation
VRS
| $63K | ﹤0.01% |
5,616
-1,576
| -22% | -$17.7K |
|
|
FLXN
2533
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $63K | ﹤0.01% |
7,938
-1,433
| -15% | -$11.4K |
|
2534
Copel
ELP
$6.94B
| $62K | ﹤0.01% |
15,003
| – | – |
|
2535
nLIGHT
LASR
$1.45B
| $62K | ﹤0.01% |
5,882
-1,457
| -20% | -$15.4K |
|
|
TBNK
2536
DELISTED
Territorial Bancorp Inc.
TBNK
| $62K | ﹤0.01% |
2,552
-379
| -13% | -$9.21K |
|
2537
Dynavax Technologies
DVAX
$1.11B
| $61K | ﹤0.01% |
17,256
-3,979
| -19% | -$14.1K |
|
2538
Ecovyst
ECVT
$1.06B
| $61K | ﹤0.01% |
5,557
-1,717
| -24% | -$18.8K |
|
2539
Lifecore Biomedical
LFCR
$280M
| $61K | ﹤0.01% |
6,957
-849
| -11% | -$7.44K |
|
2540
Vale
VALE
$45.6B
| $61K | ﹤0.01% |
7,384
| – | – |
|
|
AT
2541
DELISTED
Atlantic Power Corporation
AT
| $61K | ﹤0.01% |
28,767
-3,611
| -11% | -$7.66K |
|
|
BDSI
2542
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $61K | ﹤0.01% |
16,171
-3,752
| -19% | -$14.2K |
|
2543
CEL-SCI Corp
CVM
$70.8M
| $60K | ﹤0.01% |
174
-2
| -1% | -$690 |
|
2544
MacroGenics
MGNX
$99.9M
| $60K | ﹤0.01% |
10,318
-1,678
| -14% | -$9.76K |
|
2545
Midland States Bancorp
MSBI
$387M
| $60K | ﹤0.01% |
3,415
-1,161
| -25% | -$20.4K |
|
2546
Construction Partners
ROAD
$7.04B
| $60K | ﹤0.01% |
3,905
+773
| +25% | +$11.9K |
|
2547
Stoke Therapeutics
STOK
$1.24B
| $60K | ﹤0.01% |
2,618
+816
| +45% | +$18.7K |
|
|
ALTA
2548
DELISTED
Altabancorp Common Stock
ALTA
| $60K | ﹤0.01% |
3,107
-598
| -16% | -$11.5K |
|
|
MEET
2549
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $59K | ﹤0.01% |
10,086
-2,920
| -22% | -$17.1K |
|
|
GMRE
2550
Global Medical REIT
GMRE
$514M
| $58K | ﹤0.01% |
5,768
-1,055
| -15% | -$10.6K |
|